| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.149 | 40.944 | 62.676 | 80.158 | 75.370 | 20.775 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 30.333 | 41.375 | 63.393 | 80.737 | 75.638 | 20.931 | 7 | 27 | 43 | 7 |
| Total Expenses - EUR | 20.359 | 20.379 | 42.721 | 52.392 | 54.150 | 30.770 | 2.925 | 752 | 246 | 127 |
| Gross Profit/Loss - EUR | 9.975 | 20.996 | 20.672 | 28.345 | 21.489 | -9.839 | -2.917 | -725 | -203 | -120 |
| Net Profit/Loss - EUR | 9.070 | 19.767 | 18.786 | 27.539 | 20.735 | -10.162 | -2.917 | -725 | -203 | -120 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Future Stem Cells Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 585 | 13.090 | 7.737 | 4.443 | 1.336 | 223 | 160 | 98 | 36 |
| Current Assets | 13.926 | 22.291 | 22.360 | 52.096 | 40.880 | 12.880 | 10.621 | 10.294 | 10.136 | 10.026 |
| Inventories | 0 | 0 | 0 | 77 | 92 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.587 | 11.980 | 7.519 | 35.822 | 35.933 | 9.836 | 9.919 | 9.998 | 9.940 | 9.884 |
| Cash | 6.339 | 10.311 | 14.841 | 16.196 | 4.855 | 3.044 | 702 | 297 | 197 | 142 |
| Shareholders Funds | 10.796 | 20.139 | 23.376 | 50.486 | 39.188 | 10.304 | 7.158 | 6.456 | 6.233 | 6.078 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 3.285 | 3.136 | 12.512 | 9.974 | 6.756 | 3.984 | 3.686 | 3.999 | 4.001 | 3.984 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Future Stem Cells Srl